Trials / Conditions / Invasive Bladder Cancer

Invasive Bladder Cancer

13 registered clinical trials studyying Invasive Bladder Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Nordic Cystectomy Study III - Transfusion NCT04537221	Turku University Hospital	—
Unknown	Nordic Cystectomy Study II - Albumin NCT04523038	Turku University Hospital	—
Unknown	Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR) NCT04523025	Turku University Hospital	—
Active Not Recruiting	Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE) NCT04134000	Fundacion Oncosur	Phase 1
Completed	Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer NCT03862105	UNC Lineberger Comprehensive Cancer Center	N/A
Recruiting	A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and N NCT03844256	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Phase 1 / Phase 2
Terminated	A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer NCT03498196	Baylor College of Medicine	Phase 1 / Phase 2
Completed	Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated NCT03702179	Spanish Oncology Genito-Urinary Group	Phase 2
Completed	HIPEC After Radical Cystectomy for High Risk Bladder Cancer NCT03514888	Weill Medical College of Cornell University	N/A
Completed	Intravenous Lidocaine for Cystectomy Procedures NCT02924480	CAMC Health System	N/A
Active Not Recruiting	Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer NCT02560636	Royal Marsden NHS Foundation Trust	Phase 1
Terminated	Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not NCT02030574	Brown University	Phase 2
Withdrawn	MRI and Bladder Cancer Chemotherapy NCT01922232	NYU Langone Health	—